Sign in

CIK 0001124105

  • Accelerated filer
  • Smaller reporting company

GYRE THERAPEUTICS, INC.

Sign in to watch
Ticker
GYRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
562020050
Phone
+1 858-284-0115
Business address
12730 HIGH BLUFF DRIVE, SUITE 250, SAN DIEGO, CA, 92130
Former names
CATALYST BIOSCIENCES, INC., TARGACEPT INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-02-04 Payne Fletcher Chief Financial Officer Exercise or conversion +1,503 $4.63 $7K 3,230
2019-02-04 Payne Fletcher Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) −1,503 73,497
2019-01-31 Levy Howard Chief Medical Officer Exercise or conversion +1,500 $4.63 $7K 9,382
2019-01-31 Levy Howard Chief Medical Officer Exercise or conversion · Stock Option (Right to Buy) −1,500 93,500
2019-01-31 USMAN NASSIM President & CEO Exercise or conversion +5,729 $4.63 $27K 11,041
2019-01-31 USMAN NASSIM President & CEO Exercise or conversion · Stock Option (Right to Buy) −5,729 269,271
2019-01-24 USMAN NASSIM President and CEO Grant or award · Stock Option (Right to Buy) +80,000 80,000
2019-01-24 Payne Fletcher Chief Financial Officer Grant or award · Stock Option (Right to Buy) +38,000 38,000
2019-01-24 Levy Howard Chief Medical Officer Grant or award · Stock Option (Right to Buy) +35,000 35,000
2018-12-31 Williams Eddie Director Grant or award +1,544 1,672
2018-12-31 LAWLOR AUGUSTINE Director Grant or award +2,732 2,732
2018-12-31 Hunt Andrea Director Grant or award +811 811
2018-12-31 DESOUZA ERROL B Director Grant or award +1,703 1,944
2018-11-26 Levy Howard Chief Medical Officer Exercise or conversion +149 $4.63 $690 7,709
2018-11-26 Levy Howard Chief Medical Officer Exercise or conversion · Stock Option (Right to Buy) −149 87,118
2018-11-16 Levy Howard Chief Medical Officer Exercise or conversion +173 $4.63 $801 7,733
2018-11-16 Levy Howard Chief Medical Officer Sale −173 $11.00 $2K 7,560
2018-11-16 Levy Howard Chief Medical Officer Exercise or conversion · Stock Option (Right to Buy) −173 87,267
2018-09-06 HILL STEPHEN A Director Returned to the company −190 $10.07 $2K 1,190
2018-07-30 USMAN NASSIM President & CEO Grant or award · Stock Option (Right to Buy) +75,000 75,000

Page 19 of 24 · 471 trades